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AbsTRACT
background The English National Health Service 
NHS Stop Smoking Services (SSS), established in 2001, 
were the first such services in the world. An appropriate 
evaluation of the SSS has national and international 
significance. This modelling study sought to evaluate the 
impact of the SSS on changes in smoking prevalence in 
England.
Methods A discrete time state-transition model 
was developed to simulate changes in smoking 
status among the adult population in England during 
2001–2016. Input parameters were based on data from 
national statistics, population representative surveys 
and published literature. The main outcome was the 
percentage point reduction in smoking prevalence 
attributable to the SSS.
Results Smoking prevalence was reduced by 10.8 % 
in absolute terms during 2001–2016 in England, and 
15.3 % of the reduction could be attributable to the SSS. 
The percentage point reduction in smoking prevalence 
each year was on average 0.72%, and 0.11 % could be 
attributable to the SSS. The proportion of SSS supported 
quit attempts increased from 5.5 % in 2001, to as high 
as 18.9 % in 2011, and then reduced to 8.2 % in 2016. 
Quit attempts with SSS support had a higher success 
rate than those without SSS support (15.1% vs 11.3%). 
Smoking prevalence in England continued to decline 
after the SSS was much reduced from 2013 onwards.
Conclusions Approximately 15% of the percentage 
point reduction in smoking prevalence during 2001–
2016 in England may be attributable to the NHS SSS, 
although uncertainty remains regarding the actual 
impact of the formal smoking cessation services.
InTRoduCTIon
Cigarette smoking remains a leading cause of avoid-
able deaths worldwide.1 According to the WHO 
Framework Convention on Tobacco Control, 
comprehensive tobacco control measures include 
cigarette taxes, smoke-free laws, public informa-
tion campaigns, advertising bans, health warning 
and cessation treatment.2 Observational evidence 
indicates that the implementation of key tobacco 
control measures is associated with increased cessa-
tion rates and reduced smoking prevalence at the 
population level.3 4 However, the relative impact 
of each of the key tobacco control measures on a 
population’s smoking prevalence remains unclear,5 
although different interventions, simultaneously 
implemented, may interact in complex ways and 
have synergistic effect.
The UK is considered to be in a leading position 
in Europe regarding the implementation of tobacco 
control measures.6 Smoking prevalence among 
adults in the UK has declined from 27% in 2000 to 
16% in 2016.7 As part of a comprehensive tobacco 
control strategy, National Health Service (NHS) 
Stop Smoking Services (SSS) were launched in 
Health Action Zones in 1999 in England, and were 
rolled out to all English Health Authorities in 2001.8 
Smokers who are motivated to quit are referred by 
other health professionals or themselves to the SSS. 
The recommended total contact time for each client 
at SSS is 1.5 hours from pre-quit preparation to 4 
weeks after quitting.9 Evidence-based behavioural 
and pharmacological interventions are provided by 
smoking cessation specialists, or delivered by staff 
in primary care, pharmacy or dental practice who 
have received smoking cessation training.
Previous studies have evaluated the effects of 
the SSS on short-term quitting8 and long-term 
success rates.10 11 Other than a study using data 
from the SSS in one region in 2004,12 the impact 
of the SSS on smoking prevalence in England has 
not been comprehensively quantified. As the first 
such services in the world, an appropriate evalua-
tion of the SSS will provide empirical evidence for 
the development of tobacco control strategies in 
the UK and other countries. Based on official statis-
tical data and published literature, we developed 
a computational simulation model to quantify the 
impact of the SSS on smoking prevalence between 
2001 and 2016 in England.
MeThods
Model framework
A discrete time state-transition model13 was devel-
oped to simulate smoking prevalence among the 
adult population (≥16 years old) in England 
between 2001 and 2016. The population was 
separated into subgroups by age, sex and smoking 
status. Smoking status was classified as never 
smokers, current smokers and former smokers. As 
the cycle length of time was 1 year in simulation 
modelling, current smokers in this study included 
those who quit smoking less than 12 months 
ago. Former smokers were defined as those who 
stopped smoking for at least 12 months and were 
further classified according to time since cessation. 
The simulation was started using the adult popu-
lation structure of 2001. Population subgroups by 
age and gender were updated annually according 
to the probability of death and smoking status 
transition.
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Figure 1 Diagram of possible transitions across smoking status. D0,t, D1,t and D2,t, the number of deaths among never, current and former smokers 
in year T; N0,t, N1,t and N2,t, the number of never, current and former smokers in year t, respectively; Ptkup, the probability of taking up smoking in never 
smokers; Pquit, the probability of quitting for current smokers; Prelp, the probability of returning to smoking among former smokers; QUIT, the number of 
quitters; RELP, the number of former smokers who start to smoke again; TKUP, the number of new take-ups.
Detailed methods for the simulation modelling are provided 
in online supplementary appendix 1. The transition between 
smoking status over time was based on (1) the probability of 
current smokers who quit smoking, (2) the probability of former 
smokers who start to smoke regularly again and (3) the proba-
bility of never smokers who start to smoke regularly. Figure 1 
shows the possible transitions across never, current and former 
smokers between year (ie, at the beginning of the year) and year 
t+1. Never smokers in year t may remain as never smokers or 
may start smoking. The number of never smokers in year t+1 
equals the number of never smokers in year t minus deaths and 
new take-ups. Similarly, current smokers in year t may remain 
as current smokers or may have stopped smoking by the begin-
ning of year t+1. The number of current smokers in year t+1 
equals the number of current smokers in year t minus deaths 
and quitters, plus new take-ups in year t. Finally, the number 
of former smokers at the beginning of year t+1 is calculated by 
subtracting deaths and relapsers from, and adding new quitters 
to, the number of former smokers in year t. Exogenous inputs 
to the model included the number of people aged 16 and net 
immigrants, along with their smoking status.
data sources and parameter estimation
The 2001 mid-year population and death rates by age and sex in 
England were obtained from the Office for National Statistics.14 
To estimate the size of the population at the start of the year 
2001, we subtracted half of the difference between population 
estimates for 2000 and 2001 from the mid-year population 
in 2001. The prevalence rates for never, current and former 
smokers were based on data from General Lifestyle Surveys in 
the UK.7 15 Smoking prevalence was gender-specific and age-spe-
cific. Some of the fluctuation in the reported smoking prevalence 
rates during 2001–2016 was probably as a result of sampling 
errors. To facilitate simulation modelling, the observed age-spe-
cific and sex-specific smoking prevalence rates over time were 
smoothed by simple linear regression (online supplementary file 
1).
Relative risks for death by smoking status were based on data 
summarised by Vugrin et al.16 New smoking take-ups included 
16-year-old smokers, which were exogenously added to the 
simulated population. Then, we estimated the additional number 
of new take-ups among people aged 16–22 years in line with the 
observed increase in current and former smokers between two 
adjacent years (for details, see online supplementary file 1). The 
model allowed for relapse, with rates declining with the number 
of years quit, and it was assumed that relapse rates among those 
who quit for ≥12 months were not affected by the SSS. The risk 
of smoking relapse for former smokers was estimated according 
to the relapse curve developed by Stapleton and West.17 The 
rate of quit attempts among current smokers was estimated 
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Figure 2 Prevalence rates of never, current and former smokers in England: the observed and estimated.
using data from a series of Opinion Surveys in England18 and 
the Smoking Toolkit Study in England.19 The number of quit 
attempts supported by SSS and short-term quitters at 4 weeks 
after the quit date were based on SSS Statistics.20 The risk of 
smoking relapse by 12 months among short-term quitters was 
estimated according to data from three long-term follow-up 
studies,10 11 21 and data from the Smoking Toolkit Study.22 To be 
consistent with the self-reported smoking and cessation status in 
national surveys in England,18 we used self-reported quit rates in 
the present study.
outcomes and data analyses
The model’s outcomes include the number of current smokers 
who attempted to quit smoking and the number of smokers 
who successfully quit each year from 2001 to 2016 in England. 
The quit attempts and successful quitters were further separated 
according to whether support from the SSS was received or 
not. Due to the limited availability of relevant data, the main 
outcomes were estimated by a novel modelling approach: the 
number of quitters in year t was calculated based on the change 
in smoking prevalence between year t and t+1, given estimated 
smoking relapse, new take-ups and death (see online supplemen-
tary appendix 1: figure 2). We first calculated the number of 
current smokers at the beginning of a year by assuming there 
were no smokers who stopped smoking in the past 12 months, 
given other inflow to and outflow from the pool of current 
smokers. Then we calculated the number of current smokers 
based on the observed smoking prevalence. The difference in the 
number of current smokers between the two calculations was 
used to estimate the number of all quitters required in the past 
year to achieve the observed smoking prevalence in the current 
year. The number of quitters without SSS support was estimated 
by subtracting the estimated number of quitters with SSS support 
from the estimated number of all quitters (online supplemen-
tary appendix 1). In addition to the rates of current smokers, we 
also calibrated the relevant inflow and outflow parameters by 
comparing the estimated and observed proportions of never and 
former smokers in England.
Reduction in smoking prevalence over time is presented using 
percentage point change which is the arithmetic difference of 
two smoking prevalence rates in different years. We estimate the 
percentage point reduction in smoking prevalence attributable 
to the SSS, based on the total percentage point reduction and the 
proportion of quitters who received support from the SSS. Due 
to important changes in the SSS since 2013, including declining 
client numbers,23 public health budget cuts23 24 and increased use 
of e-cigarettes,25 26 results of the evaluation were also considered 
separately for the period 2001–2012 and 20 013–2016.
The computing language R was used to perform the simula-
tion modelling.
ResulTs
smoking status between 2001 and 2016
Figure 2 shows the observed and estimated overall prevalence of 
current, former and never smokers in the population aged ≥16 
in England during 2001–2016. As the number of quitters was 
estimated based on changes in smoking prevalence over time, the 
estimated prevalence rates for current smokers agree closely with 
the reported prevalence rates.7 15 The overall rate of smoking 
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Figure 3 Estimated number of quit attempts in England between 2001 and 2016. The estimated number included multiple quit attempts by 
individual smokers within a year. Other attempts, quit attempts without support from Stop Smoking Services; SSS, quit attempts with support from 
Stop Smoking Services.
prevalence (including those who quit smoking for <12 months) 
was estimated to be 28.6% in 2001, 20.6% in 2012 and 17.8% 
in 2016. Compared with the observed rates in 2016, the esti-
mated prevalence of never smokers in 2016 was lower (55.5% 
vs 59.5%) and the estimated rates of former smokers was higher 
(26.7% vs 23.3%). The differences between the estimated and 
observed rates of never and former smokers were likely to be a 
result of reclassification of former smokers7 27 which is consid-
ered in the discussion section.
The estimated number of current smokers (including those 
who quit smoking for <12 months) was reduced by 29.4% 
during 2001–2016, from 11.30 million in 2001 to 7.98 million 
in 2016. The absolute number of current smokers in England 
was on average reduced by approximately 211 900 each year 
during 2001–2012, and by 239 100 each year during 2013–
2016 (online supplementary appendix 2).
The estimated number of new take-ups to smoking each year 
was reduced by 37.8% during 2001–2016, from 257 300 in 
2001 to 160 100 in 2016 (online supplementary appendix 2). 
However, the number of relapsed smokers increased by 27.1%, 
from 132 800 in 2001 to 168 800 in 2016, corresponding to an 
increase in the number of former smokers (from 8.5 million in 
2001 to 12.0 million in 2016). Net immigration added around 
50 000 current smokers per year. The estimated number of the 
outflow from the population of current smokers was on average 
642 300 each year. The proportion of people contributing to the 
total outflow due to smoking cessation increased from 80.3% in 
2001 to 86.1% in 2016.
Quit attempts and success between 2001 and 2016
The estimated numbers of quit attempts in England during 
2001–2016 are shown in figure 3 (and online supplementary 
appendix 3–4). On average, there were approximately 4.58 
million quit attempts annually in England during 2001–2016. 
The number of quit attempts by current smokers peaked at 6.03 
million (60.0% of all current smokers) in 2007. On average, 
around 545 000 smokers set a quit date at SSS per year during 
2001–2016, and this accounted for 11.9% of all quit attempts. 
The number of quit attempts at SSS peaked at around 816 400 in 
2011, in contrast to a decline in the total number of quit attempts 
in England during 2007–2011 (figure 3). The proportion of SSS 
supported quit attempts increased from 5.5% in 2001, to as high 
as 18.9% in 2011, and then reduced to 8.2% in 2016.
The estimated number of long-term quitters in England was 
on average 538 400 each year during 2001–2016, and 15.3% 
of the long-term quitters received support from the SSS (online 
supplementary appendix 3). Quit attempts with SSS support had 
a higher success rate, compared with other quit attempts (15.1% 
vs 11.3%).
The estimated proportion of SSS supported quitters (15.3%) 
was linked with the assumed probability of smoking relapse and 
take-ups. Therefore, we conducted some post-hoc sensitivity 
analyses by increasing or lowering the probability of relapse and 
take-ups. If the risk of relapse and take-ups was both increased 
by 20% (consequently a larger number of quitters would be 
required to achieve the observed reduction in smoking preva-
lence), the estimated proportion of SSS supported quitters would 
be reduced to 12.3%. If the risk of relapse and take-ups was both 
reduced by 20%, the proportion of SSS supported quitters was 
increased to 17.5% during 2001–2016.
The prevalence rate for current smokers in England was reduced 
by 10.8% in absolute terms, from 28.6% in 2001 to 17.8% in 
2016. We estimate, therefore, that 1.65% (ie, 10.8×0.153) of 
the reduction in smoking prevalence during 2001–2016 was 
attributable to the SSS (table 1). The average percentage point 
reduction in smoking prevalence was 0.72% (ie, 10.8%/15) each 
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Table 1 Estimated impact of the Stop Smoking Services (SSS) on the reduction in smoking prevalence in England: 2001–2016
Year Percentage point reduction in smoking prevalence
Annual percentage point 
reduction in smoking prevalence
Average proportion of sss 
supported quitters
Annual prevalence 
reduction attributable to 
sss
2001–2012 8.0% (from 28.6% in 2001 to 20.6% in 2012) 0.727% 15.68% 0.114%
2012–2016 2.8% (from 20.6% in 2012 to 17.8% in 2016) 0.700% 14.03% 0.098%
2001–2016 10.8% (from 28.6% in 2001 to 17.8% in 2016) 0.720% 15.26% 0.110%
year from 2001 to 2016, and 0.11% percentage point reduction 
each year could be attributable to support from the SSS.
dIsCussIon
As the first such services established anywhere in the world, an 
appropriate evaluation of the SSS provides important informa-
tion for the development of public health policies regarding 
tobacco control in the UK and other countries. In the present 
study, we developed a computational model based on data 
from a variety of sources to evaluate the impact of the SSS on 
reductions in smoking prevalence in England. Our estimated 
percentage point reduction in smoking prevalence attributable to 
SSS support was 0.11% each year during 2001–2016, which was 
near the lower boundary of a previous estimate (0.1%–0.3%) 
using SSS data from one region in England during 2003–2004.12 
Another study estimated that a third of smoking prevalence 
reduction (0.24% out of 0.79%) in 2014 in England could be 
attributable to cessation aids.28 In addition, our estimated annual 
percentage point reduction (0.11%) attributable to the SSS was 
somewhat smaller than the annual percentage point reduction of 
0.157% estimated by Gravely et al3 for implementing cessation 
support at the highest level in a population. However, the two 
estimates seemed broadly consistent in scale, considering that 
our estimated percentage point reduction was attributable to the 
SSS only, and cessation treatments are also available outside the 
SSS.
The main difference in cessation support between SSS 
and non-SSS quit attempts was the provision of varenicline 
(only available on prescription) and behavioural counselling.8 
According to the results of the present study, the overall rates 
of success during 2001–2016 were higher for quit attempts with 
SSS support, compared with those without such support (15.1% 
vs 11.3%). This result is consistent with findings from previous 
studies. One study estimated that biochemically verified absti-
nence at 4 weeks was about 35% with SSS support, and 25% for 
those with only a prescription of smoking cessation medication.8 
Within the SSS, cessation support may be provided by dedicated 
cessation specialists, or by trained general practitioners, nurses, 
pharmacists or dentists.29 Evidence shows that the rate of relapse 
at 12 months is lower among short-term quitters who received 
specialist support compared with those receiving non-specialist 
support.30
The impact of cessation support will depend on how many 
current smokers initiate a quit attempt. The proportion of quit 
attempts among current smokers was highest in 2006/2007 
which may be explained by the ban on smoking in enclosed 
public places and workplaces after the introduction of smoke-
free legislation in July 2007 in England.31 The proportion of 
quit attempts with SSS support increased from 5.5% in 2001 to 
as high as 18.9% in 2011. However, the total number of quit 
attempts in England did not correspondingly increase, indicating 
a simultaneous reduction in quit attempts without SSS support 
(figure 3). Of all long-term quitters, the proportion of quitters 
who received support from the SSS reduced from 15.7% during 
2001–2012 to 14.0% during 2013–2016. Using data from 
statistics on smoking in England,7 figure 4 shows the changes in 
smoking prevalence and the implementation of several tobacco 
control measures in the UK during 1990–2016. Smoking prev-
alence was reduced by 0.30% per year during 1990–2000 and 
reduced by 0.85% per year during 2000–2007. The decline 
during 2000–2007 was at least partially attributable to both the 
SSS and the ban on smoking in public places in 2007, although 
other relevant tobacco control activities will also have contrib-
uted to this (see figure 4).31 However, the reduction in smoking 
prevalence slowed during 2007–2012, to only 0.10% per year, 
even with an increased number of SSS users. Then, the decline in 
smoking prevalence increased to 1.08% per year during 2012–
2016, in a period when the use of the SSS was much reduced. 
The recent faster reduction in smoking prevalence may be due 
to the increased use of electronic cigarettes and other tobacco 
control measures.25 26
In summary, we estimate that approximately 15% of the 
reduction in smoking prevalence during 2001–2016 in England 
was associated with the SSS. However, the actual impact of the 
SSS is likely to be smaller than this because some of the long-
term quitters with SSS support, it may be assumed, would have 
quit smoking anyway even without SSS support. In addition, the 
provision of cessation support has a limited effect on the initi-
ation of quit attempts, as revealed by the fact that an increased 
number of quit attempts with SSS support was accompanied 
with a reduced total number of quit attempts during 2007–2011.
Since 2013, the SSS has changed due to both declining client 
numbers23 and public health budget cuts,24 with much less 
support available from specialist smoking cessation advisors. 
Although specialist cessation support may not be necessary to 
all quit attempts, it may improve quit success for some. It has 
been advocated that the English SSS should be a mix of specialist 
support for a small number of smokers who really want it, brief 
support plus cessation medication for many and self-help for 
the majority.32 Future studies, including modelling evaluations, 
are required to compare different strategies of SSS and other 
tobacco control measures.
strengths and limitations
The impact of the SSS on smoking prevalence cannot be assessed 
in randomised controlled studies, and so a modelling approach is 
required. There have been several previous simulation modelling 
studies on smoking prevalence or cost-effectiveness of smoking 
cessation services in the UK.6 27 28 33 34 However, in previous 
modelling studies, the impact of cessation programmes on 
smoking prevalence was always considered as a known param-
eter, rather than an outcome of the evaluation. For example, 
a modelling study on smoking prevalence was based on the 
assumption that cessation treatment would reduce smoking 
prevalence by 4.75% during 1998–2010 in the UK.6 Using real-
world data and a novel modelling approach, the present model-
ling study is the first to assess the impact of smoking cessation 
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Figure 4 Changes in smoking prevalence and implementation of tobacco control measures in England. Smoking prevalence originally reported in 
official statistics. NHS, National Health Service; SSS, Stop Smoking Services.
services on smoking prevalence over time, by considering such 
impact as an outcome of the evaluation.
One specific feature of the present simulation modelling 
was to calibrate the number of smokers who stopped smoking 
according to the change in smoking prevalence. As expected, 
the estimated rates of smoking prevalence in England during 
2001–2016 were similar to the observed smoking prevalence. 
However, the estimated rates of never smokers were lower, and 
the estimated rates of former smokers were higher, compared 
with the reported rates based on survey studies (figure 2). These 
differences have been reported previously as the phenomenon 
of ‘reclassification’.27 That is, former smokers might consider 
themselves as never smokers after having quit for many years. In 
addition, a change in the definition of never smokers for people 
aged 16 and 17 led to an increase in the reported proportion of 
people who were never smokers in England since 2012 (from 
56.0% in 2011 to about 59.5% in 2012–2016), and simultane-
ously a reduction in rates of former smokers.7
The number of quit attempts and short-term quitters in the SSS 
was relatively certain because of availability of official statistics 
for these services. However, the number of 12 month quitters 
was estimated based on several studies of long-term outcomes 
among SSS clients. For the total number of quit attempts, we 
used data from a series of national surveys in England.18 19 It is 
unclear whether the observed fluctuations in the reported rates 
of quit attempts were true or due to sampling errors. The rates 
of smoking relapse, relative risk of death for never, current and 
former smokers are all estimated based on limited literature or 
datasets. Due to a lack of data from studies in England, we used 
data from the USA on relative risks of death for former smokers 
by time since cessation. For simplicity, we used a deterministic 
modelling approach without explicitly incorporating uncertainty 
and sampling errors, although the results on average are unlikely 
to be different after incorporating sampling errors into the simu-
lation modelling.
There are further limitations in the present study, including 
that we did not evaluate the cost-effectiveness of the SSS for 
smoking cessation. Smokers who quit smoking using SSS support 
may be systematically different from those who quit without 
SSS support. The current study focused on the overall smoking 
prevalence by age and gender, without considering differences 
in smoking prevalence by socioeconomic status. In addition, we 
focused on the impact of the SSS, and did not explicitly consider 
cessation support from other sources, including the use of e-cig-
arettes. The present study focused on the SSS in England, and 
results may not be generalisable to other nations (Scotland, Wales 
and North Ireland) in the UK. Finally, available data were insuf-
ficient to estimate how many quitters with SSS support would 
have quit smoking anyway even without SSS support. However, 
the current study provides unique empirical evidence regarding 
the impact of smoking cessation support delivered through a 
national network of formal cessation services on prevalence.
ConClusIons
Approximately 15% of the percentage point reduction in 
smoking prevalence during 2001–2016 may be attributable 
to the NHS SSS in England, although the actual impact of the 
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formal smoking cessation services remains uncertain as some 
people who stopped smoking with support from the SSS would 
have quit anyway without formal and intensive support.
What this paper adds
What is already known on this subject?
 ► The implementation of key tobacco control measures, 
including cigarette taxes, smoke-free laws, public information 
campaigns, advertising bans, health warning and cessation 
treatment, is associated with increased cessation rates and 
reduced smoking prevalence at the population level.
What important gaps in knowledge exist on this topic?
 ► The relative impact of each of the key tobacco control 
measures on a population’s smoking prevalence remains 
unclear.
 ► As the first such services in the world, the impact of the 
National Health Service Stop Smoking Services (SSS) on 
smoking prevalence in England has not been comprehensively 
quantified.
What this paper adds?
 ► Based on official statistical data and published literature, 
we developed a novel computational model to quantify the 
impact of the SSS on smoking prevalence between 2001 and 
2016 in England.
 ► Smoking prevalence was reduced by 10.8% in absolute terms 
between 2001 and 2016 in England, and approximately 15% 
of this reduction could be attributable to the SSS.
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